{"blog": [], "keywords": [{"value": "Orexigen Therapeutics Inc", "name": "organizations", "rank": "1", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Obesity", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Clinical Trials", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Cleveland Clinic", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/13/business/data-disclosure-leads-researchers-to-end-study-of-obesity-drug.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "838", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "pub_date": "2015-05-13T00:00:00Z", "news_desk": "Business", "headline": {"main": "Data Disclosure Leads Researchers to End Study of Obesity Drug"}, "print_page": null, "snippet": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "_id": "5552b10938f0d86643ac571d", "slideshow_credits": null, "abstract": null}